InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Zeocin® | Lamina-associated polypeptide 2α is required for intranuclear MRTF-A activity. | 2022 | Sci Rep | Sidorenko E. et al. | DOI: 10.1038/s41598-022-06135-5 |
| Blasticidin | CRISPR and biochemical screens identify MAZ as a cofactor in CTCF-mediated in... | 2022 | Nat Genet | Ortabozkoyun H. et al. | DOI: 10.1038/s41588-021-01008-5 |
| Puromycin | CRISPR and biochemical screens identify MAZ as a cofactor in CTCF-mediated in... | 2022 | Nat Genet | Ortabozkoyun H. et al. | DOI: 10.1038/s41588-021-01008-5 |
| Primocin® | Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell... | 2022 | Theranostics | Teijeira A. et al. | DOI: 10.7150/thno.63359 |
| Primocin® | Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinan... | 2022 | Eng Life Sci | Verbelen B. et al. | DOI: 10.1002/elsc.202100124 |
| Puromycin | Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient ... | 2022 | Mol Ther Nucleic Acids | Baron Y. et al. | DOI: 10.1016/j.omtn.2021.12.033 |
| Peptide M / Agarose | Saliva as a useful tool for evaluating upper mucosal antibody response to inf... | 2022 | PLoS One | Tsunetsugu-Yokota Y. et al. | DOI: 10.1371/journal.pone.0263419 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Compensatory intestinal antibody response against pro-inflammatory microbiota... | 2022 | Gut Microbes | Scheithauer T.P.M et al. | DOI: 10.1080/19490976.2022.2031696 |
| Human TLR5 Reporter HEK293 Cells (NF-κB) | Compensatory intestinal antibody response against pro-inflammatory microbiota... | 2022 | Gut Microbes | Scheithauer T.P.M et al. | DOI: 10.1080/19490976.2022.2031696 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
| Human TLR2 and TLR1 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
| LPS-EK (LPS from E. coli K12) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
| HEK-Blue™ Detection | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
| Human TLR2 and TLR6 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
| Puromycin | Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induc... | 2022 | Biochem J. | Chihara K. et al. | DOI: 10.1042/BCJ20210707 |
| TDB | Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induc... | 2022 | Biochem J. | Chihara K. et al. | DOI: 10.1042/BCJ20210707 |
| Pam3CSK4 | Interferon-γ primes macrophages for pathogen ligand-induced killing via a cas... | 2022 | Immunity | Simpson D.S. et al. | DOI: 10.1016/j.immuni.2022.01.003 |
| LPS-B5 (LPS from E. coli O55:B5) | Interferon-γ primes macrophages for pathogen ligand-induced killing via a cas... | 2022 | Immunity | Simpson D.S. et al. | DOI: 10.1016/j.immuni.2022.01.003 |
| Puromycin | Interferon-γ primes macrophages for pathogen ligand-induced killing via a cas... | 2022 | Immunity | Simpson D.S. et al. | DOI: 10.1016/j.immuni.2022.01.003 |